Depression in Parkinson’s disease: Health risks, etiology, and treatment options

References

• AndersonJAabroEGulmannNAnti-depressive treatment in Parkinson’s disease: a controlled trial of the effect of nortriptyline in patients with Parkinson’s disease treated with L-dopaActa Neurol Scand198062210197010875
   PubMed Web of Science ®Google Scholar
• BeckATWardCHMendelsonMAn inventory for measuring depressionArch Gen Psychiatry196145617113688369
   PubMed Web of Science ®Google Scholar
• BelNArtigasFIn vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studiesJ Pharmacol Exp Ther19962781064728819487
   PubMed Web of Science ®Google Scholar
• BergnerMBobbittRACarterWBThe sickness impact profile: development and final revision of a health status measureMed Care1981197878057278416
   PubMed Web of Science ®Google Scholar
• BodkinJAAmsterdamJDTransdermal selegiline in major depression: A double-blind, placebo-controlled, parallel-group study in outpatientsAm J Psychiatry200215918697512411221
   PubMed Web of Science ®Google Scholar
• BrodMMendoelsohnGARobertsBPatients’ experience of Parkinson’s diseaseJ Gerontol199853B21322
   Google Scholar
• BrodyALBarsomMWBotaRGPrefrontal-subcortical and limbic circuit mediation of major depressive disorderSemin Clin Neuropsychiatry200161021211296310
   PubMedGoogle Scholar
• BrownRMacCarthyBGothamAMDepression and disability in Parkinson’s disease: a follow-up study of 132 casesPsychol Med19881849553363044
   PubMed Web of Science ®Google Scholar
• BrownRMacCarthyBPsychosocial factors in Parkinson’s diseaseBr J Clin Psychol19892841522924026
   PubMed Web of Science ®Google Scholar
• BrownRJahanshashiMDepression Parkinson’s disease: a psychosocial viewpointAdv Neurol19956561847872153
   PubMedGoogle Scholar
• CaleyCFFriedmanJHDoes fluoxetine exacerbate Parkinson’s disease?J Clin Psychiatry199253278821500404
   PubMed Web of Science ®Google Scholar
• CelesiaGGWanamakerWMPsychiatric disturbances in Parkinson’s diseaseDis Nerv System19723357783
   PubMedGoogle Scholar
• CeravoloRNutiAPiccinniAParoxetine in Parkinson’s disease: effects on motor and depressive symptomsNeurology20005512161811071504
   PubMed Web of Science ®Google Scholar
• CheifetzDLGarronDCLeavittFEmotional disturbance accompanying the treatment of parkinsonism with L-DOPAClinic Pharmacol Therapeutics1971125661
   PubMed Web of Science ®Google Scholar
• CorriganMHDenahanAQWrightCEComparison of pramipexole, fluoxetine, and placebo in patients major depressionDepress Anxi2000115865
   PubMed Web of Science ®Google Scholar
• CummingsJLDepression and Parkinson’s disease: a reviewAm J Psychiatry1992149443541372794
   PubMed Web of Science ®Google Scholar
• CummingsJLFrontal-subcortical circuits and human behaviorArch Neurol199350873808352676
   PubMed Web of Science ®Google Scholar
• DakoffGAMendelsohnGAParkinson’s disease: the psychological aspects of a chronic illnessPsychol Bull198699375873714924
   PubMed Web of Science ®Google Scholar
• DakofGAMendelsohnGAPatterns of adaptation to Parkinson’s diseaseHealth Psychol19898355722767024
   PubMed Web of Science ®Google Scholar
• Dalrymple-AlfordJCKaldersASJonesRDA central executive deficit in patients with Parkinson’s diseaseJ Neurol Neurosurg Psychiatry19945736078158188
   PubMed Web of Science ®Google Scholar
• De BoerAGWijkerWSpeelmanJDQuality of life in patients with Parkinson’s disease: development of a questionnaireJ Neurol Neurosurg Psychiatry1996617048676165
   PubMed Web of Science ®Google Scholar
• DodelRCBergerKOertelWHHealth-related quality of life and healthcare necessity in patients with Parkinson’s diseasePharmacoeconomics20011910133811735671
   PubMed Web of Science ®Google Scholar
• DouyonRSerbyMKlutchkoBECT and Parkinson’s disease revisted: a “naturalistic” studyAm J Psychiatry19891461451552817117
   PubMed Web of Science ®Google Scholar
• EdwardsEKittCOliverEDepression and Parkinson’s disease: a new look at an old problemDepress Anxi2002163948
   PubMed Web of Science ®Google Scholar
• EhmannTSBeningerRJGawelMJDepressive symptoms in Parkinson’s disease: a comparison with disabled control subjectsJ Geriatr Psychiatry Neurol19903392140682
   PubMedGoogle Scholar
• EllgringHSeilerSPerlethBPsychosocial aspects of Parkinson’s diseaseNeurology199343S4148264910
   PubMed Web of Science ®Google Scholar
• EmreMWhat causes mental dysfunction in Parkinson’s disease?Mov Disord200318S637114502658
   PubMed Web of Science ®Google Scholar
• FaberRTrimbleMElectroconvulsive therapy, Parkinson’s disease and other movement disordersMov Disord19916293031758447
   PubMed Web of Science ®Google Scholar
• FahnSEltonRLFahnSMarsdenCalneDBGoldsteinMMembers of the UPDRS development committee. United parkinson’s disease rating scaleRecent developments in Parkinson’s disease19872Florham Park (NJ)Macmillan Health Care Information15364
   Google Scholar
• FlemingerSLeft-sided Parkinson’s disease is associated with greater anxiety and depressionPsychol Med199121629381946851
   PubMed Web of Science ®Google Scholar
• FrazierLDCoping with disease-related stressors in Parkinson’s diseaseThe Gerontologist200040536310750313
   PubMed Web of Science ®Google Scholar
• FrazierLDStability and change in patterns of coping with Parkinson’s diseaseInt J Aging Hum Dev2002552073112693546
   PubMed Web of Science ®Google Scholar
• FriedmanJGordonNElectroconvulsive therapy in Parkinson’s disease: a report on five casesConvulsive Therapy199282041011941171
   PubMedGoogle Scholar
• GesiMSoldaniPGiorgiFSThe role of the locus coeruleus in the development of Parkinson’s diseaseNeurosci Biobehav Rev2000246556810940440
   PubMed Web of Science ®Google Scholar
• GoetzCGTannerCMKlawansHLBupropion in Parkinson’s diseaseNeurology198434109246431314
   PubMed Web of Science ®Google Scholar
• GoodwinFKMurpheyDLBrodieHKL-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patientsBiol Psychiatry19702341664920729
   PubMedGoogle Scholar
• GothamAMBrownRGMarsdenCDDepression in Parkinson’s disease: a quantitative and qualitative analysisJ Neurol Neurosurg Psychiatry19864938193701347
   PubMed Web of Science ®Google Scholar
• HamiltonMA rating scale for depressionJournal of Neurology, Neurosurgery and Psychiatry1960235662
   PubMed Web of Science ®Google Scholar
• HauserRAZesiewiczTASertraline for the treatment of depression in Parkinson’s diseaseMov Disord19971275699380061
   PubMed Web of Science ®Google Scholar
• HobsonPHoldenAMearaJMeasuring the impact of Parkinson’s disease with the Parkinson’s disease quality of life questionnaireAge Aging1999283416
   PubMed Web of Science ®Google Scholar
• HoehnMMCrowleyTJRutledgeCODopamine correlated of neurological and psychological status in untreated parkinsonismJ Neurol Neurosurg Psychiatry197639941511003240
   PubMed Web of Science ®Google Scholar
• HornSSome psychological factors in parkinsonismJ Neurol Neurosurg Psychiatry19743727314149802
   PubMed Web of Science ®Google Scholar
• HornykiewiczOImbalance of brain monoamines and clinical disordersProg Brain Res198255419217163495
   PubMed Web of Science ®Google Scholar
• HuberSJPaulsonGWShuttleworthECDepression in Parkinson’s diseaseNeuropsychiatry Neuropsychol Behav Neurol198814751
   Google Scholar
• HughesTARossHFMusaSA 10-year study of the incidence and factors predicting dementia in Parkinson’s diseaseNeurology20005415960210762499
   PubMed Web of Science ®Google Scholar
• IndacoACarrieriPDAmitriptyline in the treatment of headache in patients with Parkinson’s diseaseNeurology198838172023054626
   PubMed Web of Science ®Google Scholar
• JenkinsonCFitzpatrickRArgyleMThe Nottingham health profile: an analysis of its sensitivity in differentiating illness groupsSoc Sci Med1988271411143070764
   PubMed Web of Science ®Google Scholar
• Jimenez-JimenezFJTejeiroJMartinez-JunqueraGParkinsonism exacerbated by paroxetineNeurology1994442406
   Web of Science ®Google Scholar
• KarlsenKHLarsenJPTandbergEInfluence of clinical and demographic variables on quality of life in patients with Parkinson’s diseaseJ Neurol Neurosurg Psychiatry199966431510201412
   PubMed Web of Science ®Google Scholar
• KeranenTKaakkolaSSotaniemiKEconomic burden and quality of life impairment increase with severity of PDParkinsonism Relat Disord20039163812573872
   PubMed Web of Science ®Google Scholar
• KimKYHersheyLADiagnosis and treatment of depression in the elderlyInt J Psychiatry Med198818211213063674
   PubMed Web of Science ®Google Scholar
• KlaassenTVerheyFRJSneijdersGHJTreatment of depression in Parkinson’s disease: a meta-analysisJ Neuropsychiatry Clin Neurosci1995728167580184
   PubMed Web of Science ®Google Scholar
• KosticVSDjuricicBMCovickovic-SternicNDepression and Parkinson’s disease: possible role of serotonergic mechanismsJ Neurol19872349462435855
   PubMed Web of Science ®Google Scholar
• KremerJStarksteinSEAffective disorders In Parkinson’s diseaseInt Rev Psychiatry2000122907
   Web of Science ®Google Scholar
• KuzisGSabeLTibertiCCognitive functions in major depression and Parkinson’s diseaseArch Neurol19975498269267973
   PubMedGoogle Scholar
• LaitinenLDesipramine in treatment of Parkinson’s diseaseActa Neurol Scand196945109134896078
   PubMed Web of Science ®Google Scholar
• LeentjensAFGVerheyFRLousbergRThe validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson’s diseaseInt J Geriatric Psychiatry2000156449
   PubMed Web of Science ®Google Scholar
• LeentjensAFGVerheyFRJLuijckxGJThe validity of the Beck Depression. Inventory as a screening and diagnostic instrument for depression in patients with parkinson’s diseaseMov Disord200061221411104209
   PubMed Web of Science ®Google Scholar
• LeentjensAFGVreelingFWLuijckxGJSSRIs in the treatment of depression in Parkinson’s diseaseInt J Geriatr Psychiatry200318552412789682
   PubMed Web of Science ®Google Scholar
• LesserRPFahnSSniderSRAnalysis of the clinical problems in parkinsonism and the complications of long term levodopa therapyNeurology197929125360573405
   PubMed Web of Science ®Google Scholar
• LevyGSchupfNTangMXCombined effect of age and severity on the risk of dementia in Parkinson’s diseaseAnn Neurol200251722912112078
   PubMed Web of Science ®Google Scholar
• LingjaerdeOAhlforsUGBechPThe UKU side effect rating scaleActa Psychiatr Scand198776Suppl 3341993630745
   PubMed Web of Science ®Google Scholar
• LombardiWJWoolstonDJRobertsJWCognitive deficits in patients with essential tremorNeurology2001577859011552004
   PubMed Web of Science ®Google Scholar
• MacCarthyBBrownRPsychosocial factors in Parkinson’s diseaseBr J ClinPsychol1989284152
   PubMed Web of Science ®Google Scholar
• MannJJAaronsSFWilnerPJA controlled study of the antidepressant efficacy and side effects of (–)-deprenyl. A selective monoamine oxidase inhibitorArch Gen Psychiatry19894645502491941
   PubMed Web of Science ®Google Scholar
• MarinusJRamakerCvan HiltenJJHealth related quality of life in Parkinson’s disease: a systematic review of disease specific instrumentsJ Neurol Neurosurg Psychiatry200272241811796776
   PubMed Web of Science ®Google Scholar
• MarshGGMarkhamCHDoes levodopa alter depression and psychopathology in parkinsonism patients?J Neurol Neurosurg Psychiatry197336925354149286
   PubMed Web of Science ®Google Scholar
• MartinSDMartinERaiSSBrain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: Preliminary findingArch Gen Psychiatry200158641811448369
   PubMed Web of Science ®Google Scholar
• MaxmenJSWardNGPsychotropic drugs: fast facts1995New York and LondonW.W. Norton and Company
   Google Scholar
• MaybergHSStarksteinSESadzotBSelective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson’s diseaseAnn Neurol19902857642375634
   PubMed Web of Science ®Google Scholar
• MaybergHSSolomonDHDepression in Parkinson’s disease: a biochemical and organic viewpointAdv Neurol19956549607872152
   PubMedGoogle Scholar
• MayeuxRSternYRosenJDepression, intellectual impairment and Parkinson’s diseaseNeurology198131645507195481
   PubMed Web of Science ®Google Scholar
• MayeuxRBehavioral manifestations movement disorders: Parkinson’s and Huntington’s diseaseNeurol Clin19842527406085395
   PubMed Web of Science ®Google Scholar
• MayeuxRSternYCoteLAltered serotonin metabolism in depressed patients with Parkinson’s diseaseNeurology19843464266200801
   PubMed Web of Science ®Google Scholar
• MayeuxRSternYWilliamsJBWClinical and biomchemical features of depression in Parkinson’s diseaseAm J Psychiatry19864375692424323
   PubMed Web of Science ®Google Scholar
• MayeuxRKollerWCThe mental status in Parkinson’s diseaseHandbook of Parkinson’s disease1992Marcel Decker Inc15984
   Google Scholar
• MenzaMAMarkMHParkinson’s disease and depression: the relationship to disability and personalityJ Neuropsychiatr Clin Neurosci199461659
   PubMed Web of Science ®Google Scholar
• MeyerowitzBEPsychosocial correlates of breast cancer and its treatmentPsychol Bull198087108317375595
   PubMed Web of Science ®Google Scholar
• MindhamRHMarsdenCDParkesJDPsychiatric symptoms during L-DOPA therapy for Parkinson’s disease and their relationship to physical disabilityPsychol Med197662333778880
   PubMed Web of Science ®Google Scholar
• MindhamRHAhmedSWCloughCGA controlled study of dementia in Parkinson’s diseaseJ Neurol Neurosurg Psychiatry198245969747175541
   PubMed Web of Science ®Google Scholar
• MoellentineCRummansTAhlskogEJEffectiveness of ECT in patients with parkinsonismJ Neuropsychiatry Clin Neurosci199810187939608407
   PubMed Web of Science ®Google Scholar
• MontastrucJLFabreNBlinODoes fluoxetine aggravate Parkinson’s disease? A pilot prospective studyMov Disord19951035577651460
   PubMed Web of Science ®Google Scholar
• MontgomerySAÅsbergMA new depression scale designed to be sensitive to changeBritish Journal of Psychiatry197913438289444788
   PubMed Web of Science ®Google Scholar
• MorrisonCBorodJBrinMA program for neuropsychological investigation of Deep Brain Stimulation (PNIDBS) in movement disorder patients: Development, feasibility, and preliminary dataNeuropsychiatry Neuropsychol Behav Neurol2000132041910910093
   PubMedGoogle Scholar
• Parkinson Study GroupEffects of tocopherol and deprenyl on the progression of disability in early Parkinson’s diseaseN Engl J Med1993328176838417384
   PubMed Web of Science ®Google Scholar
• PaulusWTrenkwalderCImaging of nonmotor symptoms in Parkinson syndromesClinl Neurosci1998511520
   PubMedGoogle Scholar
• PetoVJenkinsonCFitzpatrickRThe development and validation of a short measure of functioning and well being for individuals with Parkinson’s diseaseQual Life Res1995424187613534
   PubMed Web of Science ®Google Scholar
• PoeweWLugingerEDepression in Parkinson’s disease: impediments to recognition and treatment optionsNeurology199952S2610227602
   PubMed Web of Science ®Google Scholar
• PoeweWSeppiKTreatment options for depression and psychosis in Parkinson’s diseaseJ Neurol200124831221
   Google Scholar
• QuitkinFLiebowitzMRStewartJWL-deprenyl in atypical depressivesArch Gen Psychiatry198441777816430257
   PubMed Web of Science ®Google Scholar
• RampelloLChiechioSRaffaeleRThe SSRI, citalopram, improves bradykinesia in patients with Parkinson’s disease treated with l-dopaClin Neuropharmacol20022521411852292
   PubMed Web of Science ®Google Scholar
• RaskinSBorodJTweedyJNeuropsychological aspects of Parkinson’s DiseaseNeuropsychol Rev19901185212152531
   PubMedGoogle Scholar
• ReichmannHBrechtMHKosterJPramipexole in routine clinical practice: a prospective observational trial in Parkinson’s diseaseCNS Drugs2003179657314533946
   PubMed Web of Science ®Google Scholar
• RektorovaIRectorIBaresMPramipexole and pergolide in the treatment of depression in Parkinson’s disease: a national multicentre prospective randomized studyEur J Neurol20031039940612823492
   PubMed Web of Science ®Google Scholar
• RichardIHKurlanRA survey of antidepressant drug use in Parkinson’s disease. Parkinson Study GroupNeurology1997491168709339713
   PubMed Web of Science ®Google Scholar
• RobinsAHDepression in patients with parkinsonismBr J Psychiatry19761281415130180
   PubMed Web of Science ®Google Scholar
• RubinESackeimHANoblerMSBrain imaging studies of antidepressant treatmentsPsychiatr Ann1994246538
   Web of Science ®Google Scholar
• SagarHJClinicopathological heterogeneity and non-dopaminergic influences on behavior in Parkinson’s diseaseAdv Neurol1999804091710410749
   PubMedGoogle Scholar
• SchragAJahanshahiMQuinnNPWhat contributes to depression in Parkinson’s disease?Psychol Med200131657311200961
   PubMed Web of Science ®Google Scholar
• ScottBBorgmanHEnglerBGender differences in Parkinson’s disease symptom profileActa Neurol Scand2000102374310893061
   PubMed Web of Science ®Google Scholar
• SchragAJahanshahiMQuinnNPWhat contributes to depression in Parkinson’s disease?Psychol Med200131657311200961
   PubMed Web of Science ®Google Scholar
• SingerESociopsychological factors influencing response to levodopa therapy for Parkinson’s diseaseArch Phys Med Rehabil19765732834938217
   PubMed Web of Science ®Google Scholar
• SlaughterJRSlaughterKANicholsDPrevalence, clinical manifestations, etiology, and treatment of depression in Parkinson’s diseaseJ Neuropsychiatry Clin Neurosci2001131879611449025
   PubMed Web of Science ®Google Scholar
• StarksteinSEPreziosiTJBolducPLDepression in Parkinson’s diseaseJ Nerv Ment Dis19901783741
   Web of Science ®Google Scholar
• SternYMarderKTangMXAntecedent clinical features associated with dementia in Parkinson’s diseaseNeurology199343169028414013
   PubMed Web of Science ®Google Scholar
• SteurENIncrease of Parkinson disability after fluoxetine medicationNeurology199343211138423889
   PubMed Web of Science ®Google Scholar
• StromeEMZisAPDoudetDJElectroconvulsive shock enhances striatal dopamine D(1) and D(3) receptor binding and improves motor performance in 6-OHDA-lesioned ratsJ Psychiatry Neurosci20073219320217476366
   PubMed Web of Science ®Google Scholar
• SrinivasanJSchmidtWJPotentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in ratsEur J Neurosci20031725869212823465
   PubMed Web of Science ®Google Scholar
• SrinivasanJSchmidtWJTreatment with alpha2-adrenoceptor antagonist, 2-methoxyidazoxan, protects 6-hydroxydopamine-induced parkinsonian symptoms in rats: neurochemical and behavioral evidenceBeh Brain Res200415435363
   PubMed Web of Science ®Google Scholar
• StrangRRImipramine in treatment of Parkinsonism: a double-blind placebo studyBMJ1965233414305352
   PubMed Web of Science ®Google Scholar
• SunderlandTMullerEACohenRMTyramine pressor sensitivity changes during deprenyl treatmentPsychopharmacol19858643237
   Web of Science ®Google Scholar
• TandbergELarsenJPAarslandDRisk factors for depression in Parkinson’s diseaseArch Neurol199754625309152120
   PubMed Web of Science ®Google Scholar
• TeseiSAntoniniACanesiMTolerability of paroxetine in Parkinson’s disease: a prospective studyMov Disord200015986911009210
   PubMed Web of Science ®Google Scholar
• TrendPKayeJGageHShort-term effectiveness of intensive multidisciplinary rehabilitation for people with Parkinson’s disease and their carersClin Rehabil2002167172512428820
   PubMed Web of Science ®Google Scholar
• UekermannJDaumIPetersSDepressed mood and executive dysfunction in early Parkinson’s diseaseActa Neurol Scand2003107341812713526
   PubMed Web of Science ®Google Scholar
• WarburtonJWDepressive symptoms in Parkinson patients referred for thalamotomyJ Neurol Neurosurg Psychiatry196730368704228336
   PubMed Web of Science ®Google Scholar
• WeintraubDMoralesKHMobergPJAntidepressant studies in Parkinson’s disease: a review and meta-analysisMov Disord2005201161915954137
   PubMed Web of Science ®Google Scholar
• WermuthLSorensenPSTimmSDepression in idiopathic Parkinson’s disease treated with citalopramNord J Psychiatry1998521639
   Web of Science ®Google Scholar
• YesavageJABrinkTLRoseTLDevelopment and validation of a geriatric depression rating scale: a preliminary reportJ Psych Res1982173749
   Web of Science ®Google Scholar
• ZesiewiczTAGoldMChariGCurrent issues in depression in Parkinson’s diseaseAm J Geriatr Psychiatry199971101810322237
   PubMed Web of Science ®Google Scholar
• ZgaljardicDBorodJFoldiNA review of the cognitive and behavioral sequelae of Parkinson’s disease: Relationship to frontostriatal circuitryCogn Behav Neurol20031619321014665819
   PubMedGoogle Scholar